NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Taro Pharmaceutical Industries Ltd. (NYSE: TARO) to Sun Pharmaceutical Industries Limited for $43.00 per share in cash is fair to Taro shareholders. Halper Sadeh encourages Taro shareholders to click here to l
Full Story >>
Vote
+8